SCHEMBL4455078

SCHEMBL4455078

O=C(Nc1ccccc1-n1cccn1)N[C@H]1[C@@H]2CN(c3ccc(F)cc3F)C[C@@H]21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
KCNN4 O15554 1/20 0.44
KCNA5 P22460 1/20 0.44
ADRA1A P35348 3/20 0.40
HCRTR1 O43613 3/20 0.39
GAA P10253 3/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HCRTR2 O43614 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
POLB P06746 1/20 0.39
DRD2 P14416 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1B P35368 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
ACLY P53396 1/20 0.37
FGFR1 P11362 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13783891 1.00 ALDH1A1 (0.44) ALDH1A1KCNN4KCNA5ADRA1AHCRTR1
SCHEMBL4451787 0.89 HCRTR1 (0.40) ALDH1A1ADRA1AHCRTR1GAAMEN1
SCHEMBL13783801 0.89 HCRTR1 (0.40) ALDH1A1ADRA1AHCRTR1GAAMEN1
SCHEMBL4451792 0.89 HCRTR1 (0.40) ALDH1A1ADRA1AHCRTR1GAAMEN1
SCHEMBL13783960 0.87 NPC1 (0.41) ALDH1A1ADRA1AHCRTR1GAAMEN1
SCHEMBL4460551 0.86 KMT2A (0.52) ALDH1A1ADRA1AHCRTR1GAAMEN1
SCHEMBL4460557 0.86 KMT2A (0.52) ALDH1A1ADRA1AHCRTR1GAAMEN1
SCHEMBL4316894 0.83 NPSR1 (0.56) ALDH1A1GAAKMT2ANPC1RAB9A
SCHEMBL4316889 0.83 NPSR1 (0.56) ALDH1A1GAAKMT2ANPC1RAB9A
SCHEMBL13784018 0.83 NPSR1 (0.56) ALDH1A1GAAKMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009090548-A2 3-AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-07-23 WO claimed